TechConnect Innovation Program

Diffuse reflectance spectroscopy

Zenalux Biomedical, NC, United States

TECHNOLOGY SUMMARY

Zenalux has developed a patent-protected, photonic system that quickly and non-destructively measures important biomarkers including hemoglobin concentration, hemoglobin saturation and scattering (a measure of cell density and necrosis). The technique can be applied more widely to any turbid media beyond biological systems.

Primary Application Area: Medical Devices

Technology Development Status: Ready to Market

Technology Readiness Level: TRL 6

FIGURES OF MERIT

Value Proposition: Diffuse reflectance spectroscopy, coupled with our patented monte carlo-based algorithm, enables real-time, non-destructive biological tissue diagnostics. This technology can displace slow, more costly and invasive diagnostic methods for a variety of cancers and can be deployed for point-of-care testing.

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Showcase Booth #: 36M

Website: zenalux.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: Federal Grant

Looking for: Both Funding and Development Partners